Serum Institute of India (SII) working on vaccine for Mpox outbreak: CEO Adar Poonawalla

Following the state government’s guidelines on Mpox response, Serum Institute of India (SII) CEO Adar Poonawalla announced ongoing efforts to develop a vaccine, expecting positive results within a year. Despite testing concerns over a new Mpox lineage, experts reassured that mass vaccination is unnecessary but may prioritize high-risk groups with multiple sexual partners.